valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
733.51 | -45.65% | -23.35% | 654,235.43 | 0.71% | 3.59% |
|
NYSE:JNJ
Johnson & Johnson
|
146.14 | 0% | 0% | 356,431.01 | 3.39% | 3.91% |
|
NYSE:MRK
Merck
|
131.20 | -7.08% | 6.52% | 321,694.58 | 2.35% | -19.03% |
|
NYSE:PFE
Pfizer
|
25.40 | 19.53% | 52.98% | 147,226.07 | 6.61% | -9.31% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
883.20 | -22.88% | -16.31% | 96,373.98 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.85 | 59.34% | 69.53% | 90,596.11 | 5.35% | 13.54% |
|
NYSE:ZTS
Zoetis
|
158.42 | 50.35% | 68.97% | 66,942.77 | 1.09% | 11.57% |
|
NYSE:BAX
Baxter International Inc
|
40.13 | 63.14% | 87.8% | 20,103.93 | 2.89% | -3.14% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
143.31 | 0% | 0% | 18,260.95 | 0% | 0% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.57 | 4.85% | 15.35% | 13,360.15 | 4.15% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
233.85 | -0.15% | 10.33% | 11,196.64 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
55.92 | -57.01% | -6.2% | 10,040.45 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
65.34 | 0% | 0% | 7,941.36 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
41.59 | -,150.35% | -,143.74% | 6,374.47 | 0% | 0% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
193.33 | 0% | 0% | 5,006.79 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
139.26 | -0.18% | 9.42% | 4,629.66 | 0.57% | 4.44% |
|
NYSE:PRGO
Perrigo Co PLC
|
31.94 | 48.09% | 73.12% | 4,173.89 | 3.46% | -15.93% |
|
NasdaqGS:NEOG
Neogen
|
12.14 | 150.05% | 256.55% | 2,514.82 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
22.80 | -30.32% | -4.82% | 2,383.06 | 0% | 2.03% |
|
LSE:INDV
Indivior PLC
|
14.08 | -21.77% | 0.7% | 1,906.97 | 0% | -2.7% |
